Recombinant Human HES2 protein (denatured)
Recombinant Human HES2 protein (denatured)
Be the first to review this product! Submit a review
|
(1 Publication)
Recombinant Human HES2 protein (denatured) is a Human Full Length protein, in the 1 to 173 aa range, expressed in Escherichia coli, with >80%, suitable for SDS-PAGE.
別名を表示する
BHLHB40, HES2, Transcription factor HES-2, Class B basic helix-loop-helix protein 40, Hairy and enhancer of split 2, bHLHb40
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human HES2 protein (denatured) (AB168071)
3 μg ab168071 on 15% SDS-PAGE
Reactivity data
配列情報
出荷温度及び保存条件
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HES2 functions as a transcriptional regulator by binding to specific DNA sequences. It plays an important role in maintaining the balance between proliferation and differentiation. HES2 acts as part of the Notch signaling pathway complex. This pathway is important in numerous developmental processes including the regulation of neurogenesis and myogenesis.
Pathways
HES2 actively participates in the Notch signaling pathway and interacts with other pathway components like HEY1 and DLL1. These interactions help regulate gene expression patterns necessary for stem cell maintenance and differentiation. It also contributes to the MAPK/ERK pathway facilitating various cellular processes such as cell survival and proliferation particularly through its interactions with E proteins.
製品の性状
製品の状態
Liquid
一般的な情報
機能
Transcriptional repressor of genes that require a bHLH protein for their transcription.
細胞内局在性
Nucleus
ターゲットの情報
文献 (1)
Recent publications for all applications. Explore the full list and refine your search
Oxidative medicine and cellular longevity 2022:7676872 PubMed36238644
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com